Comments
The coronavirus vaccine market is speculated to cross five billion by 2024, owing to the constant focus by governments and vaccine manufacturers to mitigate human and economic losses triggered by the coronavirus.
The availability of vaccine doses will likely grow by 2024 as businesspersons look forward to implementing new strategies. These include combining phases 1 and 2 clinical trial stages and quick regulatory approval, as per the study by Report Linker.
Also read: 52% employees prefer hybrid model for work post-pandemic: Survey
The key findings of the study stated the factors that can contribute to this tremendous growth of the market. These include increased initiatives for inoculation, the emergence of Next Generation Vaccine Platforms for Covid-19 vaccine, and fast regulatory approvals.
The study stressed the Covid-19 vaccine market’s present scenario and its market dynamics for the forecast period 2022-2024.
The study covers a detailed overview of several market growth enablers, restraints, and trends.
The outbreak of the coronavirus pandemic has been witnessed across the globe. However, countries such as the United Kingdom, United States, Italy, Spain, India, and China have been the most affected.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.